Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Nucleainucleai.ai · Low evidenceNucleai provides an AI-driven spatial biomarker platform that analyzes complex cellular interactions in patient biopsies to accelerate drug development and diagnostics. Its technology integrates multimodal imaging data to deliver actionable insights for biomarker discovery, therapy response prediction, and precision medicine.
Parse Score